Graphene Modified Molecular Imprinting Electrochemical Sensor for Determining the Content of Dopamine

Background:

The unnatural levels of dopamine (DA) result in serious neurological disorders such as Parkinson’s disease. Electrochemical methods which have the obvious advantages of simple operation and low-cost instrumentation were widely used for determination of DA. In order to improve the measurement performance of the electrochemical sensor, molecular imprinting technique and graphene have always been employed to increase the selectivity and sensitivity.

Methods:

An electrochemical sensor which has specific selectivity to (DA) was proposed based on the combination of a molecular imprinting polymer (MIP) with a graphene (GR) modified gold electrode. The performance and effect of MIP film were investigated by differential pulse voltammetry (DPV) and cyclic voltammetry (CV) in the solution of 5.0 ×10-3 mol/L K3[Fe(CN)6] and K4[Fe(CN)6] with 0.2 mol/L KCl at room temperature.

Results:

This fabricated sensor has well repeatability and stability, and was used to determine the dopamine of urine. Under the optimized experiment conditions, the current response of the imprinted sensor was linear to the concentration of dopamine in the range of 1.0×10-7 ~ 1.0×10-5 mol/L, the linear equation was I (µA) = 7.9824+2.7210lgc (mol/L) with the detection limit of 3.3×10-8 mol/L.

Conclusion:

In this work, a highly efficient sensor for determination of DA was prepared with good sensitivity by GR and great selectivity of high special recognization ability by molecular imprinting membrane. This proposed sensor was used to determine the dopamine in human urine successfully.

Hydrogel-Based Molecularly Imprinted Polymers for Biological Detection

Molecularly imprinted polymers (MIPs) have become an important tool in the preparation of artificial and robust recognition materials that are capable of mimicking natural systems. MIPs have been regarded as 'antibody mimics' and have shown clear advantages over real antibodies for sensor technology. Currently, on-site diagnostic (OSD) and point-of-care (POC) biosensor development are heavily dominated by antibody-dependent immuno-sensors such as the lateral flow immuno-assay. Although antibodies exhibit a high degree of selectivity, any biological recognition element is inherently unstable with limited shelf-life, even when stored under optimum conditions. OSD and POC tests are essential for disease screening and treatment monitoring as part of emergency management. Introduced or naturally occurring pathogens can cause significant disruptions, raise panic in the population, and result in significant economic losses. Cheaper, smaller, and smarter devices for early detection of disease or environmental hazards ultimately lead to rapid containment and corrective action. To this end, there has been extensive research on detection platforms based on genetic or immune techniques. MIPs have proven to produce selective biological extractions that rival immunoaffinity-based separations, but without the tediously lengthy time-consuming process. MIPs could provide an alternative to antibodies, and ultimately lead to cheaper, smaller, and smarter biosensors.